HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mehar Chand Sharma Selected Research

3-hydroxyphenyltrimethylammonium

1/2022Overexpression of prothymosin-α in glioma is associated with tumor aggressiveness and poor prognosis.
5/2011Overexpression of prothymosin alpha predicts poor disease outcome in head and neck cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mehar Chand Sharma Research Topics

Disease

34Neoplasms (Cancer)
10/2022 - 08/2002
11Glioma (Gliomas)
01/2022 - 06/2004
9Glioblastoma (Glioblastoma Multiforme)
07/2021 - 06/2004
7Ependymoma
04/2021 - 05/2018
4Oligodendroglioma
08/2018 - 06/2004
4Multiple Myeloma
05/2016 - 04/2012
4Astrocytoma (Pilocytic Astrocytoma)
06/2006 - 01/2004
3Drug Resistant Epilepsy
07/2022 - 06/2006
3Hypoxia (Hypoxemia)
02/2022 - 04/2013
3Necrosis
03/2016 - 04/2011
3Osteosarcoma (Osteogenic Sarcoma)
11/2015 - 04/2011
3Medulloblastoma
11/2005 - 08/2002
2Inflammation (Inflammations)
07/2022 - 10/2018
2Hippocampal Sclerosis
07/2022 - 10/2021
2Temporal Lobe Epilepsy
07/2022 - 10/2021
2Neoplasm Metastasis (Metastasis)
02/2022 - 07/2016
2Adenoid Cystic Carcinoma (Cylindroma)
02/2022 - 12/2021
2Primitive Neuroectodermal Tumors (PNET)
07/2021 - 01/2021
2Lymphoma (Lymphomas)
01/2019 - 08/2018
2Hyperplasia
08/2016 - 05/2011
2Meningioma (Meningiomas)
07/2016 - 07/2014
2Carcinoma (Carcinomatosis)
10/2015 - 10/2011
2Squamous Cell Carcinoma of Head and Neck
01/2012 - 05/2011
1Multiple Endocrine Neoplasia Type 2b (MEN 3)
09/2022
1Thyroid Neoplasms (Thyroid Cancer)
09/2022
1Thalassemia
01/2022
1Intellectual Disability (Idiocy)
01/2022
1Disease Progression
11/2021
1Lymphadenopathy
10/2019
1Pancytopenia
10/2019
1Residual Neoplasm
10/2019
1Fever (Fevers)
07/2019
1Epstein-Barr Virus Infections
07/2019
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
07/2019
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
07/2019
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2019
1Burkitt Lymphoma (Burkitt's Lymphoma)
07/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018
1Confusion (Bewilderment)
09/2017
1Craniopharyngioma (Craniopharyngiomas)
07/2017
1Nasopharyngeal Carcinoma
01/2017
1Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
01/2017

Drug/Important Bio-Agent (IBA)

14Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2002
7DNA (Deoxyribonucleic Acid)IBA
04/2016 - 12/2010
6Biological ProductsIBA
09/2022 - 08/2002
6Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2022 - 12/2010
5Biomarkers (Surrogate Marker)IBA
08/2016 - 01/2012
5MethyltransferasesIBA
04/2016 - 12/2010
5ErbB Receptors (EGF Receptor)IBA
03/2014 - 06/2006
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2022 - 04/2013
4Temozolomide (Temodar)FDA LinkGeneric
07/2021 - 12/2010
3Transcription Factors (Transcription Factor)IBA
07/2020 - 10/2018
3Methotrexate (Mexate)FDA LinkGeneric
01/2019 - 11/2015
3SynaptophysinIBA
03/2016 - 01/2004
23-hydroxyphenyltrimethylammoniumIBA
01/2022 - 05/2011
2Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
01/2021 - 05/2018
2Melanins (Melanin)IBA
10/2020 - 03/2016
2Histones (Histone)IBA
01/2017 - 12/2014
2Messenger RNA (mRNA)IBA
01/2017 - 07/2013
2Angiopoietin-2IBA
07/2013 - 04/2013
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
07/2013 - 04/2013
2AngiopoietinsIBA
07/2013 - 04/2013
1NitrogenIBA
10/2022
1MucinsIBA
09/2022
1Calcitonin (Calcitonin, Eel)FDA LinkGeneric
09/2022
1Transforming Growth Factor beta (TGF-beta)IBA
07/2022
1Activating Transcription Factor 3IBA
07/2022
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
03/2022
1Nuclear Proteins (Protein, Nuclear)IBA
01/2022
1Notch1 ReceptorIBA
12/2021
1Glutamate Receptors (Glutamate Receptor)IBA
10/2021
1KynurenineIBA
10/2021
1Muramidase (Lysozyme)IBA
11/2020
1Long Noncoding RNAIBA
07/2020
1Cadherins (E-Cadherin)IBA
07/2020
1GlobulinsIBA
10/2019
1AlbuminsIBA
10/2019
1PerforinIBA
07/2019
1Anaplastic Lymphoma KinaseIBA
01/2019
1Rituximab (Mabthera)FDA Link
01/2019
1Cytokine Receptors (Cytokine Receptor)IBA
10/2018
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
10/2018
1MicroRNAs (MicroRNA)IBA
08/2018
1NF-kappa B (NF-kB)IBA
05/2018
1NestinIBA
05/2018
1Glucose (Dextrose)FDA LinkGeneric
01/2018
1PlatinumIBA
01/2018
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2018
1AcidsIBA
09/2017
1CateninsIBA
07/2017
1amsonic acid (DAS)IBA
01/2017

Therapy/Procedure

10Drug Therapy (Chemotherapy)
08/2018 - 05/2007
10Therapeutics
03/2015 - 08/2002
9Radiotherapy
11/2021 - 08/2003
2Adjuvant Radiotherapy
07/2021 - 10/2006
2Neoadjuvant Therapy
10/2011 - 04/2011
1Immunotherapy
10/2019
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
07/2019
1Conformal Radiotherapy
01/2019
1Chemoradiotherapy
01/2017